BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23659478)

  • 1. Striking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
    Büchel GE; Gavriluta A; Novak M; Meier SM; Jakupec MA; Cuzan O; Turta C; Tommasino JB; Jeanneau E; Novitchi G; Luneau D; Arion VB
    Inorg Chem; 2013 Jun; 52(11):6273-85. PubMed ID: 23659478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmium(III) analogues of KP1019: electrochemical and chemical synthesis, spectroscopic characterization, X-ray crystallography, hydrolytic stability, and antiproliferative activity.
    Kuhn PS; Büchel GE; Jovanović KK; Filipović L; Radulović S; Rapta P; Arion VB
    Inorg Chem; 2014 Oct; 53(20):11130-9. PubMed ID: 25290960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Os(IV)Cl(5)(Hazole)](-) complexes: synthesis, structure, spectroscopic properties, and antiproliferative activity.
    Büchel GE; Stepanenko IN; Hejl M; Jakupec MA; Arion VB; Keppler BK
    Inorg Chem; 2009 Nov; 48(22):10737-47. PubMed ID: 19842663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].
    Büchel GE; Stepanenko IN; Hejl M; Jakupec MA; Keppler BK; Arion VB
    Inorg Chem; 2011 Aug; 50(16):7690-7. PubMed ID: 21739939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure, spectroscopic properties, and antiproliferative activity in vitro of novel osmium(III) complexes with azole heterocycles.
    Stepanenko IN; Krokhin AA; John RO; Roller A; Arion VB; Jakupec MA; Keppler BK
    Inorg Chem; 2008 Aug; 47(16):7338-47. PubMed ID: 18597450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osmium NAMI-A analogues: synthesis, structural and spectroscopic characterization, and antiproliferative properties.
    Cebrián-Losantos B; Krokhin AA; Stepanenko IN; Eichinger R; Jakupec MA; Arion VB; Keppler BK
    Inorg Chem; 2007 Jun; 46(12):5023-33. PubMed ID: 17497853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism elucidation of the cis-trans isomerization of an azole ruthenium-nitrosyl complex and its osmium counterpart.
    Gavriluta A; Büchel GE; Freitag L; Novitchi G; Tommasino JB; Jeanneau E; Kuhn PS; González L; Arion VB; Luneau D
    Inorg Chem; 2013 Jun; 52(11):6260-72. PubMed ID: 23675748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Tetrachlorido-bis(indazole)osmium(iv) and its osmium(iii) analogues: paving the way towards the cis-isomer of the ruthenium anticancer drugs KP1019 and/or NKP1339.
    Büchel GE; Kossatz S; Sadique A; Rapta P; Zalibera M; Bucinsky L; Komorovsky S; Telser J; Eppinger J; Reiner T; Arion VB
    Dalton Trans; 2017 Sep; 46(35):11925-11941. PubMed ID: 28850133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
    Novak MS; Büchel GE; Keppler BK; Jakupec MA
    J Biol Inorg Chem; 2016 Jun; 21(3):347-56. PubMed ID: 26961253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolysis and cytotoxic properties of osmium(II)/(III)-DMSO-azole complexes. Short communication.
    Egger A; Cebrián-Losantos B; Stepanenko IN; Krokhin AA; Eichinger R; Jakupec MA; Arion VB; Keppler BK
    Chem Biodivers; 2008 Aug; 5(8):1588-1593. PubMed ID: 18729098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole.
    Reisner E; Arion VB; Rufińska A; Chiorescu I; Schmid WF; Keppler BK
    Dalton Trans; 2005 Jul; (14):2355-64. PubMed ID: 15995743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.
    Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK
    Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A SAR study of novel antiproliferative ruthenium and osmium complexes with quinoxalinone ligands in human cancer cell lines.
    Ginzinger W; Mühlgassner G; Arion VB; Jakupec MA; Roller A; Galanski MS; Reithofer M; Berger W; Keppler BK
    J Med Chem; 2012 Apr; 55(7):3398-413. PubMed ID: 22417128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential.
    Jakupec MA; Reisner E; Eichinger A; Pongratz M; Arion VB; Galanski MS; Hartinger CG; Keppler BK
    J Med Chem; 2005 Apr; 48(8):2831-7. PubMed ID: 15828821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the binding of cis/trans-[MCl4(1H-indazole)(NO)](-) (M = Ru, Os) complexes to human serum albumin.
    Dömötör O; Rathgeb A; Kuhn PS; Popović-Bijelić A; Bačić G; Enyedy EA; Arion VB
    J Inorg Biochem; 2016 Jun; 159():37-44. PubMed ID: 26908285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osmium(IV) complexes with 1H- and 2H-indazoles: tautomer identity versus spectroscopic properties and antiproliferative activity.
    Büchel GE; Stepanenko IN; Hejl M; Jakupec MA; Keppler BK; Heffeter P; Berger W; Arion VB
    J Inorg Biochem; 2012 Aug; 113():47-54. PubMed ID: 22687494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
    Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
    J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential.
    Kuhn PS; Pichler V; Roller A; Hejl M; Jakupec MA; Kandioller W; Keppler BK
    Dalton Trans; 2015 Jan; 44(2):659-68. PubMed ID: 25385191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
    Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
    J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteropentanuclear Oxalato-Bridged nd-4f (n=4, 5) Metal Complexes with NO Ligand: Synthesis, Crystal Structures, Aqueous Stability and Antiproliferative Activity.
    Kuhn PS; Cremer L; Gavriluta A; Jovanović KK; Filipović L; Hummer AA; Büchel GE; Dojčinović BP; Meier SM; Rompel A; Radulović S; Tommasino JB; Luneau D; Arion VB
    Chemistry; 2015 Sep; 21(39):13703-13. PubMed ID: 26260662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.